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42 ABSTRACT 
43 Objectives: We investigated if serum total testosterone (T)-level is associated with knee pain and 
44 function in men and women with severe knee osteoarthritis (OA).
45 Methods: We enrolled 272 adults ≥60 years (70.4±4.4 years, 53% women) who underwent 
46 unilateral total knee replacement (TKR) due to severe knee OA. Serum T-levels and WOMAC 
47 pain and function of the operated and contra-lateral knee were measured at 6-8 weeks after 
48 surgery. At the non-operated knee, 56% participants had radiographic knee OA with a Kellgren-
49 Lawrence grade ≥2. Cross-sectional analyses were performed by gender and BMI subgroups using 
50 multivariable regression adjusted for age, physical activity and BMI. 
51 Results: At the operated knee, higher T-levels were associated with less WOMAC pain in men (B 
52 = -0.62; P = 0.046) and women (B = -3.79; P = 0.02), and less WOMAC disability scores in 
53 women (B = -3.62; P = 0.02) and obese men (B = -1.99; P = 0.02). At the non-operated knee, T-
54 levels were not associated with WOMAC pain in men or women, but higher T-levels were 
55 associated with less disability in women (B = -0.95; P = 0.02). T-levels were inconsistently 
56 associated with pain and disability in BMI subgroups among men. Only among obese women, T-
57 levels were inversely associated with radiographic knee OA (OR = 0.10; P = 0.003). 
58 Conclusions: Higher total T-levels were associated with less pain in the operated knee in men and 
59 women undergoing TKR and less disability in women. At the non-operated knee, higher T-levels 
60 were inconsistently associated with less pain and disability.
61  
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62 Significance & Innovation
63  Among both men and women with severe knee osteoarthritis who underwent unilateral 
64 total knee replacement, higher serum testosterone levels were associated with less 
65 WOMAC pain in the operated knee, independent of age, BMI and physical activity.
66  Among women but not men, higher serum testosterone levels were also associated with 
67 less WOMAC disability in the operated and the non-operated knee, independent of age, 
68 BMI and physical activity.
69
70
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72 INTRODUCTION
73 Knee osteoarthritis (OA) is the most common cause of difficulty walking in older adults (1). 
74 Thirty percent of adults will develop symptomatic knee OA by the age of 65 and nearly 50 percent 
75 of adults will develop symptomatic knee OA by the age of 85 years, with the highest risk among 
76 those who were overweight during extended periods of their lifetime (2). 
77 Prevalence of symptomatic knee OA increases similarly with age in women and men until the age 
78 of 50. In the second half of life, women have a significantly higher prevalence of symptomatic 
79 knee OA (3) and greater disability from knee OA than men (4, 5). The gender difference in knee 
80 OA prevalence and severity in the second half of life has not been well understood (4, 6). 
81 However, given that cells in knee articular cartilage, underlying bone and surrounding muscles in 
82 men and women, express receptors for both estrogen and testosterone (T) (7, 8), it is likely that 
83 hormonal factors are involved (4, 6) with a potential benefit of a greater physiological T-exposure 
84 (7, 9-11). 
85 With regard to changes in T-exposure with age, T-levels have been shown to decrease by 
86 approximately 1% per year in men starting at age 40 (12). Clinical signs of T-deficiency in older 
87 men are a decrease in muscle mass and strength, a decrease in bone mass and an increase in 
88 central body fat (13). Women have 20-fold lower T-levels compared to men (14), and their T-
89 levels also decline with age reaching a nadir after menopause with a decline close to 15% of their 
90 premenopausal stage (15). Although the biological role of T in women remains unclear, the sharp 
91 and rapid decline after menopause may contribute to the age-related decline in physical function 
92 among women (7, 9-11, 16).
93 With regard to studies that link T-levels to OA, lower serum T-levels have been associated with a 
94 higher prevalence of hand but not knee OA in one study (17). Further, a small cross-sectional 
95 study among 45 healthy middle-aged men suggested a positive association between higher serum 
96 T-levels and medial tibial cartilage thickness (9). In one larger study of 309 overweight adults age 
97 60 years and older with knee OA, higher T-levels were found to be associated with less WOMAC 
98 stiffness among men and better WOMAC function among women (18). 
99 With regard to pain sensitivity and potential relevance to OA, clinical and experimental 
100 investigations have consistently shown gender-specific differences for both pain sensitivity and 
A
cc
ep
te
d
 A
rt
ic
le
© 2019 The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on 
behalf of American College of Rheumatology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
101 threshold (19). Although the underlying mechanisms for these differences are not well understood, 
102 an influence of T on nociceptive processing is well established (19, 20). In fact, it has been 
103 suggested that T protects men from chronic musculoskeletal pain conditions (21), either by a 
104 direct effect on nociceptive processing (19, 20), or indirectly by an increase in muscle mass, 
105 strength, and function as suggested by two clinical trials with T-treatment among frail and 
106 hypogonadal older men (22, 23). Further potential benefits of higher physiological T-levels on OA 
107 pain and function may be explained by prior data that linked higher T-exposure to a decrease in fat 
108 mass and inflammatory response among men (7, 9-11). Further, preoperative supra-physiological 
109 T-administration has been suggested to confer some early functional benefit among older men 
110 undergoing knee replacement in a small study of 25 men (24).
111 The aim of this cross-sectional study was to investigate a possible association between total serum 
112 T-levels and symptoms of knee OA with regard to pain and disability in the operated and non-
113 operated knee among men and women age 60 years and older, who underwent unilateral total knee 
114 replacement (TKR) due to severe knee OA 6 to 8 weeks earlier. We chose this target population 
115 given their high risk of OA at the contra-lateral non-operated knee (25, 26) as well as the potential 
116 shared benefits of higher physiological T-levels on pain and disability at the operated and non-
117 operated knee.
118
119
120 PATIENTS AND METHODS
121 Study design and Participants
122 The present study is a cross-sectional analysis of the baseline data from the Zurich Multiple 
123 Endpoint Vitamin D Trial in Knee OA Patients (NCT00599807; clinicaltrials.gov) (27). The 
124 original study was a 2-year double blind randomized controlled trial that investigated the effect of 
125 Vitamin D (2000 vs. 800 IU/d cholecalciferol) on pain and disability related to the rehabilitation 
126 of the operated knee and contra-lateral knee among 273 seniors age 60 years and older (mean age 
127 70.3 years, 53% women) who underwent elective surgery for unilateral TKR due to severe knee 
128 OA. The baseline assessment took place 6-8 weeks after surgery at the Centre on Aging and 
129 Mobility at the University of Zurich, Switzerland, from October 2007 to February 2013. In the A
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130 original trial, participants were not selected based on their vitamin D status and 31.4% of 
131 participants were vitamin D deficient at baseline (27). Of 273 participants enrolled, one male 
132 participant was excluded due to missing data on serum T-concentration reducing the analytical 
133 sample size for this study to 272 (for the radiologic assessment data was only available for 270 
134 participants). Exclusion criteria of the original trial were history of inflammatory arthritis, chronic 
135 corticosteroid use, history of malabsorption disorder, kidney disease (estimated creatinine 
136 clearance <30 mL/min), current cancer, treatment with bisphosphonate, PTH hormone therapy, 
137 calcitonin therapy in the 6 months prior to enrolment, severe cognitive/visual/hearing 
138 impairments, inability to walk at least 3 meters with or without a walking aid (27). All participants 
139 gave their written informed consent and the study was approved by the Cantonal Ethical 
140 Commission of Zurich (Protocol identifier STZ 20/07), Switzerland.
141
142 Measurement of serum T-concentration 
143 Fasting blood samples were taken between 8:00 and 9:30 am. Serum concentration of total T was 
144 measured by an electrochemoluminesence immunoassay (Roche Diagnostics, Rotkreuz, 
145 Switzerland) with an inter-assay coefficient of variation (CV) of 3.9% at a level of 7.3 nmol/L and 
146 3.5% at a level of 18.8 nmol/L. 
147
148 Assessment of covariates
149 Body mass index (BMI, in kg/m2) was calculated as weight divided by height squared. BMI 
150 categories were defined according to WHO guidelines as underweight (BMI < 18.5 kg/m2), 
151 normal weight (BMI ≥ 18.5 and < 25 kg/m2), overweight (BMI ≥ 25 and < 30 kg/m2), and obese 
152 (≥ 30 kg/m2).
153 Physical activity levels were measured by an ankle-worn ambulatory activity monitor 
154 (StepWatchTM Step Activity Monitor, Cyma, Seattle, WA), which records the number of steps 
155 taken every minute. The StepWatch monitor has been validated for use in older adults (28) and has 
156 been used to monitor physical activity in several patient groups including patients with knee OA 
157 (29). In the current study, participants were instructed to wear the monitor during the day for 
158 seven consecutive days. A measurement was considered as valid if at least three days with ≥10 A
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159 hours of recording were available, omitting blocks of >180 minutes of consecutive zeros, which 
160 was interpreted as device not worn. Minutes spent on moderate to vigorous physical activity 
161 (MVPA) were defined as the average minutes per day with ≥30 steps/min according to the 
162 manufacturer’s software manual (StepWatchTM 3.1 Software Manual).
163
164 Outcome measurements
165 Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and function 
166 score
167 Knee pain and function (disability) of the operated and the non-operated knee were assessed by 
168 the respective subscales of the WOMAC questionnaire. The WOMAC is a broadly validated and 
169 commonly used self-reported outcome tool for knee OA (30), including patients undergoing knee 
170 replacement (31). It consists of 24 items divided into 3 subscales: pain (5 items), stiffness (2 
171 items) and physical function (17 items), with each item scoring on a 5-point Likert scale (none, 
172 mild, moderate, severe, and extreme). For the pain and physical function subscale, these scores 
173 were transformed to a 0 to 100 score (0 = no symptoms, 100 = extreme symptoms) with higher 
174 scores indicating more pain and more disability. We used a knee-specific paper-version of the 
175 German WOMAC 3.1 (32).
176
177 Radiologic Assessment of knee osteoarthritis at the non-operated knee 
178 To rate knee OA at the non-operated knee, we performed a plain x-ray of the contra-lateral knee in 
179 a semi-flexed weight-bearing position (we used the Multicentre Osteoarthritis Study (MOST) 
180 study centre standardized X-ray assessment procedures (33)). Kellgren-Lawrence (KL) grades 
181 were classified by a blinded knee OA radiology expert (0 = no radiographic features of 
182 osteoarthritis; 1 = possible joint space narrowing and osteophyte formation; 2 = definite 
183 osteophyte formation with possible joint space narrowing; 3 = multiple osteophytes, definite joint 
184 space narrowing, sclerosis and possible bony deformity; 4 = large osteophytes, marked joint space 
185 narrowing, severe sclerosis and definite bone deformity) (34). 
186
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187 Statistical analysis
188 Statistical analysis was performed using SAS version 9.4 (SAS Institute, Inc., Cary, North 
189 Carolina, USA). Distributions of continuous variables were examined for normality. Differences 
190 in baseline characteristics between men and women were analyzed by using a χ2 test for 
191 categorical variables and a Student’s t test for continuous variables. 
192 Associations between serum T-concentration and WOMAC pain and function (disability) score 
193 were analyzed by using multivariable robust linear regression models. For these analyses, among 
194 women only, T-levels were natural logarithmically (ln) transformed to approach normality. At the 
195 non-operated knee only, we also assessed the association between T-levels and KL grades based 
196 on ordinal logistic regression models. All analyses were performed in an unadjusted way (Model 
197 1) and adjusted for age, BMI status (normal weight, overweight, obese; except in BMI strata), and 
198 physical activity (Model 2); and for men and women separately. For all analyses Model 2 was 
199 considered the main model. Moreover, we performed subgroup analysis by BMI (normal weight, 
200 overweight, and obese) to investigate whether specific BMI subgroups of seniors are more 
201 sensitive with regard to the relation between T and WOMAC scores or KL grades. These analyses 
202 were performed because obesity is a very well documented risk factor for knee OA (35, 36) and 
203 several studies have shown that T-levels are inversely associated with BMI (37, 38).
204 Statistical significance was set at P ≤ 0.05; reported P values are two-sided. 
205
206
207 RESULTS
208 The characteristics of the 272 study participants (127 men and 145 women) are shown in Table 1. 
209 There were no significant differences between men and women with regard to mean age, BMI, 
210 and KL grades. Women were significantly less physically active and had lower serum T-levels 
211 than men. Moreover, women had significantly worse (higher) WOMAC pain and more disability 
212 (higher WOMAC function scores) at the operated knee and worse disability (higher WOMAC 
213 function scores) at the non-operated knee compared with men. At the non-operated knee, 48.4% 
214 (61/126) of men and 61.6% (90/144) of women had KL grade 2 or higher consistent with 
215 radiographic knee OA.
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216 In multivariable-adjusted analyses, at the operated knee (Table 2, Model 2), higher T-levels were 
217 associated with less WOMAC pain in both men (B = -0.62; 95% CI: -1.23, -0.01; P = 0.05) and 
218 women (B = -3.79; 95% CI: -6.90, -0.69; P = 0.02). This association was most pronounced in the 
219 subgroup of normal-weight men (B = -1.16; 95% CI: -2.17, -0.15; P = 0.02) as well as in the 
220 subgroup of normal-weight women (B = -9.27; 95% CI: -15.56, -2.98; P = 0.004). At the operated 
221 knee, higher T-levels were also associated with less disability among obese men (B = -1.99; 95% 
222 CI: -3.62, -0.37; P = 0.02) and less disability among all women (B = -3.62; 95% CI: -6.65, -0.58; 
223 P = 0.02), and most pronounced among normal-weight women (B = -6.54; 95% CI: -12.81, -0.28; 
224 P = 0.04). 
225 At the non-operated knee (Table 2), higher T-levels were associated with less WOMAC pain only 
226 in normal-weight men (B = -0.39; 95% CI: -0.68, -0.10; P = 0.009). Further, at the non-operated 
227 knee, higher T-levels were associated with less disability (better WOMAC function), among all 
228 women (B = -0.95; 95% CI: -1.73, -0.17; P = 0.02). With regard to the association between T-
229 level and KL-grade, only among obese women (Table 3), per one nmol/L increase in T-level, the 
230 odds of a higher KL-grade was reduced 10-fold (OR = 0.10; 95% CI: 0.02, 0.45; P = 0.003). 
231
232
233
234 DISCUSSION
235 In this cross-sectional study among 272 men and women with severe knee OA who underwent 
236 unilateral TKR 6 to 8 weeks prior to enrolment, we found an association of T-level with symptoms 
237 of OA in the operated and the non-operated knee. Specifically, among both men and women, 
238 higher serum T-levels were associated with less WOMAC pain in the operated knee. Further, 
239 among women but not men, higher serum T-levels were also associated with less WOMAC 
240 disability in the operated and the non-operated knee. Notably, these associations were independent 
241 of age, BMI, and physical activity. With regard to subgroups by BMI, there were inconsistent 
242 signals for men in the non-operated knee. Further, only among obese women, higher T-levels were 
243 associated with less radiographic changes due to knee OA. Consistent with the literature (25, 26), 
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244 48% of men and 42% of women had radiographic knee OA at the non-operated knee according to 
245 standardized x-rays performed in all participants.
246 Our findings are consistent with an earlier study describing a non-significant inverse association 
247 between T-level and WOMAC disability among women and WOMAC stiffness among men with 
248 symptomatic knee OA age 60 years and older (18). As outlined in the introduction of this 
249 manuscript, a potential benefit of T-level with regard to pain and disability among patients with 
250 severe knee OA could be explained by prior findings supporting a positive association of higher T-
251 levels with better muscle strength (39, 40) and better muscle function (41) in patients with knee 
252 OA. Further, an influence of T on nociceptive processing (19, 20) and inflammatory response has 
253 been suggested in several studies (7, 9-11), all of which are considered important pathways in the 
254 development of OA (42, 43). 
255 Except among obese women, we did not find an association between T-levels and radiographic 
256 changes of knee OA despite the high prevalence of radiographic OA at the non-operated knee in 
257 our study. On the one hand, this is in line with prior studies where symptoms and the extent of 
258 radiographic changes show discrepant findings (36, 44). On the other hand, we may have missed 
259 such an association due to the sample selection, where the most severely affected knee had 
260 undergone surgery and could not be assessed radiographically with respect to KL grade. Notably, 
261 however, symptoms are considered the patient-relevant feature of OA rather than the extent of 
262 radiographic changes (45).
263 Our study has several strengths. The results for the association of T levels and pain are consistent 
264 for men and women at the operated knee, and disability for women at the operated and non-
265 operated knee. Also, our study has a moderately large sample size with 272 men and women age 
266 60 years and older. Further, we used the WOMAC questionnaire considered the gold standard for 
267 pain and disability measurement among patients with knee OA with and without TKR (31, 46). 
268 Finally, WOMAC scores of our study are representative of those reported in the literature among 
269 similar patient groups (47, 48). 
270 Our study also has limitations. Its cross-sectional design does not allow the exploration of cause 
271 and effect. Also, our study is a secondary analysis of a randomized controlled trial not powered for 
272 the association of T-level and symptoms of knee OA. Therefore, it is possible that the study was 
273 underpowered to show significant results for all subgroups. Further, assessments were obtained 6 A
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274 to 8 weeks after unilateral TKR. Thus, it is possible that analgesic regimens, and especially the use 
275 of opioid pain medications (49), may have influenced the association between T-levels and 
276 WOMAC pain and disability. Notably, in one large cross-sectional study (NHANES) (50), 
277 participants on opioids had a higher odds of having low T-levels than those unexposed to opioids, 
278 which is consistent with further literature suggesting that opioids can suppress gonadal hormone 
279 production possibly reducing T-levels (49). Unfortunately, we were not able to explore the 
280 potential confounding by use of pain medication (and specifically opioid use) on pain and 
281 disability in our study. However, all participants were recruited in a stable health state, 6 to 8 
282 weeks after surgery with rehabilitation efforts largely completed, and thereby reduced likelihood 
283 of exposure to opioid pain medications. 
284 In summary, the present study suggests a possible advantage of higher gender-specific 
285 physiological T-levels among both men and women undergoing unilateral TKR due to severe knee 
286 OA. Additional studies with a prospective design are needed to further explore and clarify the role 
287 of higher physiological T-levels in patients with symptomatic knee OA.
288
A
cc
ep
te
d
 A
rt
ic
le
© 2019 The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on 
behalf of American College of Rheumatology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES
1. Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson PW, et al. The effects of 
specific medical conditions on the functional limitations of elders in the Framingham Study. Am J 
Public Health 1994;84:351-8.
2. Murphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, et al. Lifetime risk of 
symptomatic knee osteoarthritis. Arthritis Rheum 2008;59:1207-13.
3. Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM. Incidence of symptomatic hand, hip, and 
knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 
1995;38:1134-41.
4. Hame SL, Alexander RA. Knee osteoarthritis in women. Curr Rev Musculoskelet Med 
2013;6:182-7.
5. Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D, Jones G. A meta-analysis of sex 
differences prevalence, incidence and severity of osteoarthritis. Osteoarthritis Cartilage 
2005;13:769-81.
6. O'Connor MI. Osteoarthritis of the hip and knee: sex and gender differences. Orthop Clin North 
Am 2006;37:559-68.
7. Koelling S, Miosge N. Sex differences of chondrogenic progenitor cells in late stages of 
osteoarthritis. Arthritis Rheum 2010;62:1077-87.
8. Ushiyama T, Ueyama H, Inoue K, Ohkubo I, Hukuda S. Expression of genes for estrogen receptors 
alpha and beta in human articular chondrocytes. Osteoarthritis Cartilage 1999;7:560-6.
9. Cicuttini FM, Wluka A, Bailey M, O'Sullivan R, Poon C, Yeung S, et al. Factors affecting knee 
cartilage volume in healthy men. Rheumatology (Oxford) 2003;42:258-62.
10. Trigunaite A, Dimo J, Jørgensen TN. Suppressive effects of androgens on the immune system. Cell 
Immunol 2015;294:87-94.
11. Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Additive benefit of higher testosterone levels 
and vitamin D plus calcium supplementation in regard to fall risk reduction among older men 
and women. Osteoporos Int 2008;19:1307-14.
12. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, et al. Age trends in the 
level of serum testosterone and other hormones in middle-aged men: longitudinal results from 
the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589-98.A
cc
ep
te
d
 A
rt
ic
le
© 2019 The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on 
behalf of American College of Rheumatology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, et al. Testosterone 
therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice 
guideline. J Clin Endocrinol Metab 2010;95:2536-59.
14. Goodman-Gruen D, Barrett-Connor E. Sex differences in the association of endogenous sex 
hormone levels and glucose tolerance status in older men and women. Diabetes Care 
2000;23:912-8.
15. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four-hour mean plasma testosterone 
concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 
1995;80:1429-30.
16. Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M. The role of androgens and estrogens on 
healthy aging and longevity. J Gerontol A Biol Sci Med Sci 2012;67:1140-52.
17. Sowers MF, Hochberg M, Crabbe JP, Muhich A, Crutchfield M, Updike S. Association of bone 
mineral density and sex hormone levels with osteoarthritis of the hand and knee in 
premenopausal women. Am J Epidemiol 1996;143:38-47.
18. Miller GD, Nicklas BJ, Davis CC, Legault C, Messier SP. Basal growth hormone concentration 
increased following a weight loss focused dietary intervention in older overweight and obese 
women. J Nutr Health Aging 2012;16:169-74.
19. Maurer AJ, Lissounov A, Knezevic I, Candido KD, Knezevic NN. Pain and sex hormones: a review 
of current understanding. Pain management 2016;6:285-96.
20. Gupta S, McCarson KE, Welch KM, Berman NE. Mechanisms of pain modulation by sex hormones 
in migraine. Headache 2011;51:905-22.
21. Cairns BE, Gazerani P. Sex-related differences in pain. Maturitas 2009;63:292-6.
22. Srinivas-Shankar U, Roberts SA, Connolly MJ, O'Connell MD, Adams JE, Oldham JA, et al. Effects of 
testosterone on muscle strength, physical function, body composition, and quality of life in 
intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J 
Clin Endocrinol Metab 2010;95:639-50.
23. Storer TW, Basaria S, Traustadottir T, Harman SM, Pencina K, Li Z, et al. Effects of Testosterone 
Supplementation for 3 Years on Muscle Performance and Physical Function in Older Men. J Clin 
Endocrinol Metab 2017;102:583-93.
A
cc
ep
te
d
 A
rt
ic
le
© 2019 The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on 
behalf of American College of Rheumatology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24. Amory JK, Chansky HA, Chansky KL, Camuso MR, Hoey CT, Anawalt BD, et al. Preoperative 
supraphysiological testosterone in older men undergoing knee replacement surgery. J Am 
Geriatr Soc 2002;50:1698-701.
25. Gunther KP, Sturmer T, Sauerland S, Zeissig I, Sun Y, Kessler S, et al. Prevalence of generalised 
osteoarthritis in patients with advanced hip and knee osteoarthritis: the Ulm Osteoarthritis 
Study. Ann Rheum Dis 1998;57:717-23.
26. McMahon M, Block JA. The risk of contralateral total knee arthroplasty after knee replacement 
for osteoarthritis. J Rheumatol 2003;30:1822-4.
27. Bischoff-Ferrari HA, Orav EJ, Egli A, Dawson-Hughes B, Fischer K, Staehelin HB, et al. Recovery 
after unilateral knee replacement due to severe osteoarthritis and progression in the 
contralateral knee: a randomised clinical trial comparing daily 2000 IU versus 800 IU vitamin D. 
RMD Open 2018;4:e000678.
28. Resnick B, Nahm ES, Orwig D, Zimmerman SS, Magaziner J. Measurement of activity in older 
adults: reliability and validity of the Step Activity Monitor. J Nurs Meas 2001;9:275-90.
29. White DK, Tudor-Locke C, Zhang Y, Fielding R, LaValley M, Felson DT, et al. Daily walking and the 
risk of incident functional limitation in knee osteoarthritis: an observational study. Arthritis Care 
Res (Hoboken) 2014;66:1328-36.
30. Brazier JE, Harper R, Munro J, Walters SJ, Snaith ML. Generic and condition-specific outcome 
measures for people with osteoarthritis of the knee. Rheumatology (Oxford) 1999;38:870-7.
31. Bombardier C, Melfi CA, Paul J, Green R, Hawker G, Wright J, et al. Comparison of a generic and a 
disease-specific measure of pain and physical function after knee replacement surgery. Med Care 
1995;33:AS131-44.
32. Stucki G, Meier D, Stucki S, Michel BA, Tyndall AG, Dick W, et al. [Evaluation of a German version 
of WOMAC (Western Ontario and McMaster Universities) Arthrosis Index]. Z Rheumatol 
1996;55:40-9.
33. Thorlund JB, Felson DT, Segal NA, Nevitt MC, Niu J, Neogi T, et al. Effect of Knee Extensor 
Strength on Incident Radiographic and Symptomatic Knee Osteoarthritis in Individuals With 
Meniscal Pathology: Data From the Multicenter Osteoarthritis Study. Arthritis Care Res 
(Hoboken) 2016;68:1640-6.
34. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 
1957;16:494-502.A
cc
ep
te
d
 A
rt
ic
le
© 2019 The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on 
behalf of American College of Rheumatology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
35. Zheng H, Chen C. Body mass index and risk of knee osteoarthritis: systematic review and meta-
analysis of prospective studies. BMJ Open 2015;5:e007568.
36. Felson DT. The epidemiology of knee osteoarthritis: results from the Framingham Osteoarthritis 
Study. Semin Arthritis Rheum 1990;20:42-50.
37. DeFina LF, Radford NB, Leonard D, Wilson RK, Cooper TC, Clark SM, et al. The association of 
cardiorespiratory fitness, body mass index, and age with testosterone levels at screening of 
healthy men undergoing preventive medical examinations: The Cooper Center Longitudinal 
Study. Maturitas 2018;118:1-6.
38. Deutschbein T, Mann K, Petersenn S. Total Testosterone and Calculated Estimates for Free and 
Bioavailable Testosterone: Influence of Age and Body Mass Index and Establishment of Sex-
Specific Reference Ranges. Horm Metab Res 2015;47:846-54.
39. Nam YS, Lee G, Yun JM, Cho B. Testosterone Replacement, Muscle Strength, and Physical 
Function. The world journal of men's health 2018;36:110-22.
40. Magnussen LV, Hvid LG, Hermann AP, Hougaard DM, Gram B, Caserotti P, et al. Testosterone 
therapy preserves muscle strength and power in aging men with type 2 diabetes-a randomized 
controlled trial. Andrology 2017;5:946-53.
41. Metcalfe D, Watts E, Masters JP, Smith N. Anabolic steroids in patients undergoing total knee 
arthroplasty. BMJ Open 2012;2.
42. Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman B, Aliabadi P, et al. Risk factors for 
incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum 
1997;40:728-33.
43. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new 
insights. Part 1: the disease and its risk factors. Ann Intern Med 2000;133:635-46.
44. Hannan MT, Felson DT, Pincus T. Analysis of the discordance between radiographic changes and 
knee pain in osteoarthritis of the knee. J Rheumatol 2000;27:1513-7.
45. Zhang W, Doherty M, Peat G, Bierma-Zeinstra MA, Arden NK, Bresnihan B, et al. EULAR evidence-
based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis 2010;69:483-9.
46. Escobar A, Quintana JM, Bilbao A, Aróstegui I, Lafuente I, Vidaurreta I. Responsiveness and 
clinically important differences for the WOMAC and SF-36 after total knee replacement. 
Osteoarthritis Cartilage 2007;15:273-80.
A
cc
ep
te
d
 A
rt
ic
le
© 2019 The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on 
behalf of American College of Rheumatology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
47. Waimann CA, Fernandez-Mazarambroz RJ, Cantor SB, Lopez-Olivo MA, Zhang H, Landon GC, et al. 
Cost-effectiveness of total knee replacement: a prospective cohort study. Arthritis Care Res 
(Hoboken) 2014;66:592-9.
48. Gstoettner M, Raschner C, Dirnberger E, Leimser H, Krismer M. Preoperative proprioceptive 
training in patients with total knee arthroplasty. Knee 2011;18:265-70.
49. Katz N, Mazer NA. The impact of opioids on the endocrine system. The Clinical journal of pain 
2009;25:170-5.
50. Cepeda MS, Zhu V, Vorsanger G, Eichenbaum G. Effect of Opioids on Testosterone Levels: Cross-
Sectional Study using NHANES. Pain Med 2015;16:2235-42.
A
cc
ep
te
d
 A
rt
ic
le
© 2019 The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on 
behalf of American College of Rheumatology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLES
TABLE 1 
Characteristics of participants of the Zurich Knee Osteoarthritis trial by gender
 Men Women Gender difference (P) Total population
Subjects [n (%)] 126 (47) 146 (53) 0.25 272
Age a (y) 70.3 (6.9) 70.4 (6.0) 0.83 70.4 (6.4)
Body mass index (kg/m2) 27.6 (3.8) 26.9 (4.1) 0.11 27.2 (3.9)
Physical activity (min MVPA/day) 45.3 (23.4) 37.9 (21.6) 0.009 42.3 (22.6)
Total testosterone (nmol/L) 13.0 (4.6) 0.4 (0.4) <0.0001 6.3 (7.0)
Kellgren-Lawrence grade [n (%)] a
0 32 (56) 25 (44) 0.11 57 (21)
1 33 (53) 29 (47) 62 (23)
2 18 (33) 36 (67) 54 (20)
3 31 (42) 42 (58) 73 (27)
4 12 (50) 12 (50) 24 (9)
WOMAC pain score (0-100)
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Operated knee 23.9 (14.4) 32.6 (14.4) <0.0001 28.5 (15.0)
Non-operated knee 4.2 (8.1) 5.2 (8.2) 0.32 4.7 (8.1)
WOMAC functional score (0-100)
Operated knee 21.8 (12.6) 29.2 (13.9) <0.0001 25.8 (13.8)
Non-operated knee 2.9 (6.6) 5.4 (8.9) 0.01 4.3 (8.0)
Data are crude means (± SD) or n (%). Differences between men and women were assessed by using Student’s t test for continuous variables 
and a χ2 test for categorical variables. P values are two-sided; statistical significance is set at P < 0.05.  Abbreviations: MVPA, moderate to 
vigorous physical activity; WOMAC, Western Ontario and McMaster Universities Arthritis Index.  
a Values refer to the non-operated knee (n = 270).
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TABLE 2
Cross-sectional association between blood total testosterone concentration and Western Ontario and McMaster Universities Arthritis Index (WOMAC) post-
operative pain and functional scores in seniors age 60 and older with knee osteoarthritis by gender 
Men Womena 
Model 1 Model 2 Model 1 Model 2
B (95% CI) P B (95% CI) P B (95% CI) P B (95% CI) P
WOMAC pain score (0-100)
 Operated knee
Total subjects (M/F) -0.51 (-1.11, 0.09) 0.09 -0.62 (-1.23, -0.01) 0.05 -2.76 (-5.75, 0.23) 0.07 -3.79 (-6.90, -0.69) 0.02
Body mass index (kg/m2)
Normal weight (18.5-24.9) b -1.25 (-2.23, -0.27) 0.013 -1.16 (-2.17, -0.15) 0.02 -5.67 (-11.81, 0.48) 0.07
-9.27 (-15.56, -
2.98)
0.004
Overweight (25.0-29.9) -0.08 (-0.87, 0.72) 0.85 -0.01 (-0.81, 0.80) 0.99 -3.54 (-7.75, 0.68) 0.10 -3.88 (-8.20, 0.43) 0.08
Obese (≥30.0) -1.12 (-3.06, 0.82) 0.26 -1.36 (-3.54, 0.82) 0.22 0.28 (-5.07, 5.63) 0.92 1.30 (-3.62, 6.22) 0.60
Pinteraction 0.29 0.38 0.09 0.01
 Non-operated knee 
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Total subjects (M/F) -0.01 (-0.11, 0.08) 0.77 -0.07 (-0.17, 0.03) 0.20 0.52 (-0.23, 1.28) 0.18 0.42 (-0.55, 1.38) 0.39
Body mass index (kg/m2)
Normal weight (18.5-24.9) b -0.27 (-0.54, 0.00) 0.050 -0.39 (-0.68, -0.10) 0.009 -0.08 (-1.10, 0.94) 0.88 0.05 (-1.43, 1.54) 0.94
Overweight (25.0-29.9) 0.0007 (-0.10, 0.10) 0.99 0.003 (-0.12, 0.13) 0.97 0.73 (-0.45, 1.91) 0.22 0.73 (-0.70, 2.16) 0.32
Obese (≥30.0) -0.63 (-1.29, 0.03) 0.06 -0.33 (-0.90, 0.24) 0.25 -0.73 (-4.98, 3.53) 0.74 0.69 (-3.51, 4.90) 0.75
Pinteraction 0.18 0.14 0.51 0.88
WOMAC functional score (0-100)
 Operated knee
Total subjects (M/F) -0.01 (-0.53, 0.51) 0.97 -0.11 (-0.66, 0.44) 0.70 -3.57 (-6.53, -0.61) 0.02 -3.62 (-6.65, -0.58) 0.02
Body mass index (kg/m2)
Normal weight (18.5-24.9) b -0.62 (-1.67, 0.44) 0.25 -0.60 (-1.77, 0.56) 0.31
-6.51 (-12.34, -
0.68)
0.03
-6.54 (-12.81, -
0.28)
0.04
Overweight (25.0-29.9) 0.31 (-0.34, 0.95) 0.35 0.31 (-0.39, 1.00) 0.39 -3.41 (-7.29, 0.47) 0.09 -4.04 (-8.12, 0.04) 0.052
Obese (≥30.0) -0.96 (-2.53, 0.61) 0.23 -1.99 (-3.62, -0.37) 0.02 -0.48 (-7.15, 6.20) 0.89 1.26 (-4.57, 7.08) 0.67
Pinteraction 0.95 0.71 0.13 0.11
 Non-operated knee 
Total subjects (M/F) -0.0005 (-0.04, 0.03) 0.98 -0.0006 (-0.03, 0.03) 0.97 -0.66 (-1.33, 0.01) 0.05 -0.95 (-1.73, -0.17) 0.02
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Body mass index (kg/m2)
Normal weight (18.5-24.9) b 0.04 (-0.32, 0.39) 0.83 0.02 (-0.25, 0.30) 0.88 0.07 (-0.62, 0.76) 0.85 0.05 (-0.82, 0.92) 0.91
Overweight (25.0-29.9) 0.004 (-0.01, 0.02) 0.64 -0.0006 (-0.20, 0.20) 0.87 -1.02 (-2.09, 0.04) 0.06 -1.24 (-2.49, 0.02) 0.054
Obese (≥30.0) -0.07 (-0.28, 0.15) 0.55 0.001 (-0.02, 0.02) 0.99 -2.89 (-5.25, -0.53) 0.02 -2.50 (-5.14, 0.14) 0.06
Pinteraction 0.35 0.16 0.17 0.13
Data (n = 272) are unstandardized regression coefficients (B) and 95% confidence intervals (95% CIs) for the association between blood total testosterone 
concentration (nmol/L) and WOMAC pain and functional scores derived from multivariable linear robust regression models unadjusted (Model 1) or adjusted for 
age, BMI status (normal weight, overweight, and obese; except BMI strata) and moderate to vigorous physical activity (Model 2) for men and women separately. 
P values are two-sided and uncorrected; statistical significance was set at P ≤ 0.05. Abbreviations: BMI, body mass index; F, females; M, males; WOMAC, 
Western Ontario and McMaster Universities Arthritis Index.
a In women, the blood concentration of total testosterone was natural logarithmically (ln) transformed to approach normality.
b One female senior was marginally underweight with BMI = 18.2. 
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TABLE 3
Cross-sectional association between blood total testosterone concentration and Kellgren-Lawrence grade in participants of the Zurich Knee Osteoarthritis trial 
stratified by gender a
Men Women 
Model 1 Model 2 Model 1 Model 2
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
Kellgren-Lawrence grade (0-4)
Total subjects (M/F) 1.01 (0.94, 1.08) 0.84 1.00 (0.93, 1.08) 0.90 0.54 (0.25, 1.19) 0.13 0.66 (0.29, 1.50) 0.32
Body mass index (kg/m2)
Normal weight (18.5-24.9) a 1.03 (0.90, 1.19) 0.67 0.99 (0.85, 1.15) 0.89 1.63 (0.23, 11.53) 0.62 2.85 (0.31, 26.32) 0.35
Overweight (25.0-29.9) 0.98 (0.89, 1.07) 0.59 0.99 (0.90, 1.08) 0.75 1.01 (0.30, 3.39) 0.99 0.94 (0.27, 3.26) 0.93
Obese (≥30.0) 1.10 (0.89, 1.38) 0.38 1.11 (0.87, 1.41) 0.39 0.21 (0.05, 0.87) 0.03 0.10 (0.02, 0.45) 0.003
Pinteraction 0.54 0.72 0.11 0.06
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Data (n = 270) are odds ratios (OR) and 95% confidence intervals (95% CIs) for the association between blood total testosterone concentration (nmol/L) and Kellgren-
Lawrence grade derived from ordinal logistic regression models unadjusted (Model 1) or adjusted for age, BMI status (normal weight, overweight, obese; except BMI 
strata) and moderate to vigorous physical activity (Model 2) for men and women separately. P values are two-sided and uncorrected; statistical significance is set at P ≤ 
0.05. Bolded P values indicate a statistical significance at P < 0.05 level. Abbreviations: BMI, body mass index; F, females; M, males.  
a One female senior was marginally underweight with BMI = 18.2 kg/m2.  
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